Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,043 | 275 | 71.2% |
| Travel and Lodging | $2,853 | 11 | 28.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $3,554 | 159 | $0 (2020) |
| Boston Scientific Corporation | $1,890 | 17 | $0 (2024) |
| Medtronic, Inc. | $858.32 | 29 | $0 (2024) |
| Abbott Laboratories | $565.36 | 21 | $0 (2024) |
| Stimwave Technologies Incorporated | $443.52 | 6 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $361.37 | 4 | $0 (2019) |
| Nevro Corp. | $308.54 | 10 | $0 (2019) |
| Depomed, Inc. | $275.77 | 5 | $0 (2017) |
| SPR Therapeutics, Inc | $236.87 | 5 | $0 (2023) |
| PAINTEQ LLC | $177.20 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.73 | 7 | PAINTEQ LLC ($77.20) |
| 2023 | $764.09 | 18 | Medtronic, Inc. ($234.27) |
| 2022 | $509.68 | 15 | Medtronic, Inc. ($333.66) |
| 2021 | $413.91 | 16 | Medtronic, Inc. ($274.44) |
| 2020 | $2,070 | 32 | Boston Scientific Corporation ($1,714) |
| 2019 | $1,779 | 86 | Medtronic USA, Inc. ($842.59) |
| 2018 | $3,144 | 76 | Medtronic USA, Inc. ($2,193) |
| 2017 | $1,059 | 36 | Medtronic USA, Inc. ($276.68) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/01/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/19/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $54.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/24/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Neuromodulation | ||||||
| 04/14/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Gastroenterology | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Pain Management | ||||||
| 12/11/2023 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/04/2023 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $137.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/04/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $66.00 | General |
| Category: Pain management | ||||||
| 11/04/2023 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $38.44 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/25/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.19 | General |
| 10/02/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $46.61 | General |
| 08/31/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/28/2023 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/08/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/07/2023 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $30.10 | General |
| Category: Pain Management | ||||||
| 06/08/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/23/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $62.02 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/26/2023 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/19/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/18/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $89.81 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/13/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Pain management | ||||||
| 01/16/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,234 | 5,697 | $813,315 | $421,192 |
| 2022 | 25 | 1,004 | 4,621 | $573,197 | $311,846 |
| 2021 | 20 | 530 | 2,047 | $191,273 | $83,165 |
| 2020 | 19 | 560 | 1,787 | $184,717 | $73,349 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G2172 | All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project | Office | 2023 | 118 | 295 | $147,500 | $97,571 | 66.1% |
| G2086 | Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month | Office | 2023 | 132 | 320 | $160,100 | $90,836 | 56.7% |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 2023 | 95 | 293 | $117,200 | $77,162 | 65.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 723 | $144,600 | $66,747 | 46.2% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 59 | 714 | $42,840 | $12,832 | 30.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 37 | 54 | $20,750 | $9,048 | 43.6% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 66 | 126 | $18,900 | $7,498 | 39.7% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2023 | 35 | 359 | $21,540 | $7,205 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $18,300 | $6,763 | 37.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 26 | 98 | $14,700 | $5,968 | 40.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 20 | 28 | $10,500 | $5,490 | 52.3% |
| 97810 | Acupuncture, initial 15 minutes | Office | 2023 | 51 | 188 | $14,100 | $5,281 | 37.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 37 | 53 | $12,150 | $4,613 | 38.0% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 20 | 183 | $10,980 | $4,459 | 40.6% |
| 97811 | Acupuncture, each additional 15 minutes | Office | 2023 | 52 | 187 | $11,220 | $3,959 | 35.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 15 | 19 | $5,750 | $2,987 | 51.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 19 | 21 | $5,250 | $2,405 | 45.8% |
| 97813 | Acupuncture with electrical stimulation, initial 15 minutes | Office | 2023 | 25 | 58 | $5,800 | $1,943 | 33.5% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 15 | 19 | $3,450 | $1,536 | 44.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 30 | $4,530 | $1,432 | 31.6% |
| 97814 | Acupuncture with electrical stimulation, each additional 15 minutes | Office | 2023 | 22 | 52 | $3,900 | $1,392 | 35.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 12 | 17 | $2,850 | $1,322 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 17 | $2,550 | $1,074 | 42.1% |
| 97012 | Application of mechanical traction | Office | 2023 | 18 | 122 | $5,435 | $996.58 | 18.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $700.00 | $243.88 | 34.8% |
About Dr. Ganesh Balu, M.D
Dr. Ganesh Balu, M.D is a Electrodiagnostic Medicine healthcare provider based in Dover, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073594693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ganesh Balu, M.D has received a total of $9,896 in payments from pharmaceutical and medical device companies, with $156.73 received in 2024. These payments were reported across 286 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,043).
As a Medicare-enrolled provider, Balu has provided services to 3,328 Medicare beneficiaries, totaling 14,152 services with total Medicare billing of $889,552. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Dover, DE
- Active Since 11/10/2005
- Last Updated 01/09/2024
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1073594693
Products in Payments
- SUPERION (Device) $1,714
- ADAPTIVESTIM (Device) $1,360
- INTELLIS (Device) $974.60
- VECTRIS (Device) $744.02
- BELBUCA (Drug) $361.37
- INTELLIS ADAPTIVESTIM (Device) $331.23
- Senza Spinal Cord Stimulation System (Device) $308.54
- RESTORE (Device) $245.09
- SPRINT PNS System (Device) $236.87
- SYNCHROMED (Device) $234.70
- PAINTEQ (Device) $177.20
- Proclaim Family of SCS IPGs (Device) $172.34
- Nucynta (Drug) $171.39
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $137.25
- VANTA ADAPTIVESTIM (Device) $133.93
- SPECIFY (Device) $125.77
- ZOHYDRO ER (Drug) $125.00
- Brainsway Deep TMS (Device) $116.90
- Gralise (Drug) $104.38
- Octrode SCS Leads (Device) $104.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.